Analyst Price Target is $4.83
▲ +192.93% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for CareRx in the last 3 months. The average price target is $4.83, with a high forecast of $5.25 and a low forecast of $4.25. The average price target represents a 192.93% upside from the last price of $1.65.
Current Consensus is
The current consensus among 1 polled investment analysts is to buy stock in CareRx. This Buy consensus rating has held steady for over two years.
CareRx Corp. engages in the provision of pharmacy and other healthcare services. It offers services for patients, solutions for insurers, solutions for employers, and solutions for long term care homes and retirement residences. The company was founded by Brenda Rasmussen on February 2, 2001 and is headquartered in Toronto, Canada.